US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

24 deals · US$77bndisclosed · Diagnostics · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Oct 2026 Select assets of BioReference Health OPKO HealthLabcorpAsset saleAnnounced–Diagnostics+1 Lazard
Sep 2026 MLM Medical Labs –LabcorpAcquisitionAnnounced–Clinical Trial Services+1 William BlairEvercore (buy-side)Pierson Ferdinand (buy-side)Hogan Lovells Cadwalader (buy-side)
Aug 2026 Lantheus Holdings –Curium US HoldingsAcquisitionAnnounced8,000.0Radiopharmaceuticals+1 Morgan Stanley (sell-side)BofA Securities (sell-side)Solomon Partners (sell-side)Covington & Burling (sell-side)Ropes & Gray (sell-side)Jefferies (buy-side)J.P. Morgan (buy-side)PJT Partners (buy-side)Kirkland & Ellis (buy-side)Arnold & Porter (buy-side)
Jul 2026 Personalis –Tempus AIAcquisitionAnnounced1,900.0Diagnostics+2 Centerview Partners (sell-side)TD Securities (sell-side)Cooley (sell-side)Morgan Stanley (buy-side)Latham & Watkins (buy-side)
Jul 2026 XpresSpa Holdings XWELLExpress Wellness GroupAcquisitionAnnounced13.0Consumer Services+2 Roth Capital Partners (sell-side)Haynes Boone (sell-side)Dechert (buy-side)
Jul 2026 Dreampath Diagnostics –HalmaAcquisitionAnnounced–Diagnostics+1 Latham & Watkins (sell-side)
Jul 2026 VitalRads ThriveZoetisAcquisitionAnnounced–Animal Health+1 Guggenheim Securities (sell-side)
Jun 2026 Bio-Techne –Merck KGaAAcquisitionPending11,300.0Life Sciences+1 Goldman Sachs (sell-side)Sidley Austin (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Guggenheim Securities (buy-side)J.P. Morgan (buy-side)Sullivan & Cromwell (buy-side)
Jun 2026 Ignite Proteomics AditxtProposed Ignite Proteomics Inc. holding companyMergerPending150.0Life Sciences+2 Ladenburg Thalmann
Jun 2026 Vesica Health –Photocure ASAAcquisitionCompleted30.5Diagnostics DNB Carnegie (buy-side)Morgan Lewis (buy-side)Selmer (buy-side)
May 2026 PathAI –RocheAcquisitionPending750.0Healthcare Software+2 Latham & Watkins (sell-side)Davis Polk (buy-side)
Apr 2026 Naveris –CareDxAcquisitionAnnounced160.0Diagnostics+1 J.P. Morgan (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Goldman Sachs (buy-side)Fenwick & West (buy-side)
Apr 2026 Thermo Fisher Scientific's microbiology division Thermo Fisher ScientificAstorgAsset saleAnnounced1,075.0Diagnostics+1 Cravath, Swaine & Moore (sell-side)Perella Weinberg Partners (sell-side)Latham & Watkins (buy-side)Moelis & Company (buy-side)
Mar 2026 Biocare Medical –Agilent TechnologiesAcquisitionAnnounced950.0Diagnostics+1 Sullivan & Cromwell (buy-side)
Feb 2026 Masimo –DanaherAcquisitionAnnounced9,900.0Medtech+1 McDermott Will & SchulteCenterview Partners (sell-side)Morgan Stanley (sell-side)Sullivan & Cromwell (sell-side)White & Case (sell-side)Longacre Square Partners (sell-side)Citi (buy-side)Kirkland & Ellis (buy-side)
Feb 2026 LKC Technologies DW Healthcare PartnersAMETEKAcquisitionAnnounced–Medtech+2 William Blair (sell-side)
Jan 2026 Lantheus SPECT business LantheusSHINE TechnologiesAsset saleAnnounced–Pharma+2 Solomon Partners (sell-side)
2026 Sebia –Warburg PincusStakeAnnounced–Diagnostics Moelis & Company (buy-side)
Dec 2025 FONAR –Timothy R. DamadianAcquisitionAnnounced–Medtech+2 Marshall & Stevens (sell-side)DLA Piper (sell-side)
Dec 2025 Bako Diagnostics selected assets –Fulgent GeneticsAcquisitionCompleted56.9Diagnostics+1 Latham & Watkins (sell-side)Piper Sandler (buy-side)Mintz (buy-side)
Dec 2025 Freenome Holdings –Perceptive Capital Solutions CorpMergerCompleted725.0Diagnostics+2 TD Securities (sell-side)Guggenheim Securities (sell-side)BTIG (sell-side)Goodwin (sell-side)Greenberg Traurig (sell-side)Richards, Layton & Finger (sell-side)H.C. Wainwright & Co. (sell-side)Jefferies (buy-side)Leerink Partners (buy-side)Cooley (buy-side)Ropes & Gray (buy-side)Maples Group (buy-side)Ogier (buy-side)Scalar (buy-side)
Nov 2025 Exact Sciences –AbbottAcquisitionAnnounced23,000.0Diagnostics Centerview Partners (sell-side)XMS Capital Partners (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Wachtell, Lipton, Rosen & Katz (buy-side)
Jul 2025 DiamiR Biosciences Corp. –Aptorum GroupMergerCompleted–Diagnostics+1 H.C. Wainwright & Co. (sell-side)
Jul 2025 BD Biosciences & Diagnostic Solutions business Becton, Dickinson and CompanyWatersAsset saleCompleted18,800.0Life Sciences+2 Citi (sell-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Barclays (buy-side)Kirkland & Ellis (buy-side)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built